Calcitonin Gene-related Peptide Receptor Antagonist — Patent Landscape

Aggregated US Orange Book patent estate across every drug in the calcitonin gene-related peptide receptor antagonist class. 1 active patents protecting 1 drugs. First major cliff: 2031. Daily refresh.

1
Drugs in class
1
Active US patents
76/100
Avg vulnerability
—
Annual revenue covered

Originators

Pfizer 1 patents

Cliff calendar — next 15 years

1
31

Drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Zavzpret
Zavegepant Hydrochloride
 Pfizer 1 76 — 2031-10-07

Most attackable patents

Patent Drug Type Vuln Expiry
8481546 Zavzpret method of use 76 2031-10-07

Strongest defences

Patent Drug Type Vuln Expiry
8481546 Zavzpret method of use 76 2031-10-07

Related